The Effects of Fx-1006A on Transthyretin Stabilization and Clinical Outcome Measures in Patients With Non-V30M Transthyretin Amyloidosis

This study has been completed.

Study NCT00630864 Information provided by Pfizer

First Received: February 27, 2008 Last Updated: June 3, 2011 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been completed.
Study Completion Date:	January 2010
Primary Completion Date:	January 2010 (Final data collection date for primary outcome measure)
Certification - "Seeking New Use":	Submission Date: October 12, 2010